Atrial natriuretic peptide predicts impaired atrial remodeling and occurrence of late postoperative atrial fibrillation after surgery for symptomatic aortic stenosis

Cardiology

Volumn 105, Issue 4, 2006, Pages 207-212

  Yilmaz, Mehmet Birhan ^a,c   Erbay, Ali Riza ^b   Balci, Mustafa ^b   Guray, Yesim ^b   Cihan, Gokhan ^b   Guray, Umit ^b   Kisacik, Halil L ^b   Korkmaz, Sule ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Yuksek Ihtisas Education and Research Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Atrial fibrillation; Atrial natriuretic peptide; Cardioconversion; Stenosis; Valvuloplasty

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGE; AGED; AORTA STENOSIS; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HUMAN; MALE; PLASMA; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULOPLASTY;

AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC;

EID: 33646683818     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091641     Document Type: Article

References (18)

1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association/European Society of Cardiology Board: ACC/AHA/ ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in Collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-1266.
2. Carabello BA: Evaluation and management of patients with aortic stenosis. Circulation 2002;5:1746-1750.
3. Asher CR, Miller DP, Grimm RA, et al: Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998;82:892-895.
4. Uchiyama M, Satokata I, Sakai K: Plasma atrial natriuretic peptide in congenital heart disease. Acta Paediatr 1987;76:669-670.
5. Lang RE, Dieatz R, Merkel A, et al: Plasma atrial natriuretic peptide values in cardiac disease. J Hypertens 1986;4(suppl 2):119-123.
6. Qi W, Mathisen P, Kjekshus J, et al: The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol 2002;25:174-180.
7. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass: anatomic validation of the method. Circulation 1977;55:613-618.
8. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
9. Triposkiadis F, Pitsavos C, Boudoulas H, et al: Left atrial volume and function in valvular aortic stenosis. J Heart Valve Dis 1993;2:104-113.
10. Wei CM, Kao PC, Lin JT, et al: Circulating beta-atrial natriuretic factor in congestive heart failure in humans. Circulation 1993;88:1016-1020.
11. Bonow RO: New insights into the cardiac natriuretic peptides. Circulation 1996;93:1946-1950.
12. Lund O, Emmertsen K, Nielsen TT, et al: Impact of size mismatch and left ventricular function on performance of the St. Jude disc valve after aortic valve replacement. Ann Thorac Surg 1997;63:1227-1234.
13. Uchiyama M, Satokata I, Sakai K: Plasma atrial natriuretic peptide in congenital heart disease. Acta Paediatr 1987;76:669-670.
14. Dietz R, Lang RE, Purgaj J, et al: Relationships between haemodynamic parameters and concentrations of atrial natriuretic peptide in human plasma. J Hypertens 1986;4(suppl):S512-S515.
15. Gerber IL, Stewart RA, Legget ME, et al: Increased natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-1890.
16. Qi W, Mathisen P, Kjekshus J, Simonsen S, et al: Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001;142:725-732.
17. Wozakowska-Kaplon B, Opolski G, Janion M: Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation. Kardiol Pol 2003;58:255-263.
18. Erbay AR, Yilmaz MB, Balci M, et al: Atrial natriuretic peptide levels in adult patients before and after surgery for correction of atrial septal defects: relationship with atrial arrhythmias. Clin Sci (Lond) 2004;107:297-302.